Early Outcomes of a New Active Transcutaneous Bone Conduction Implant in Pediatric Patients

Area of Science:

• Otolaryngology
• Biomedical Engineering
• Pediatric Audiology

Background:

• Conductive or mixed hearing loss in children can significantly impact development.
• Traditional bone conduction devices may have limitations in comfort or efficacy.
• Active transcutaneous bone conduction systems offer a novel approach to hearing rehabilitation.

Purpose of the Study:

• To evaluate the initial surgical and audiometric outcomes of pediatric patients receiving the Cochlear Osia system.
• To assess the safety and efficacy of this new active transcutaneous bone conduction implant in a young population.
• To compare patient satisfaction with the Osia system versus previous bone conduction devices.

Main Methods:

• Retrospective case review of pediatric patients (≤18 years) implanted with the Cochlear Osia system.
• Analysis of preoperative and postoperative audiometric data, including air conduction, bone conduction, and aided thresholds.
• Calculation of functional gain and air-bone gap; review of surgical complications and patient-reported satisfaction.

Main Results:

• Sixteen pediatric patients (20 implants) showed significant improvement in hearing thresholds, with an average postoperative aided threshold of 21.2 dB.
• Mean functional gain was 43.1 dB, indicating substantial hearing improvement.
• One case of postoperative seroma was managed conservatively; no other major complications were reported. Patients favored the Osia system over previous devices.

Conclusions:

• The active transcutaneous bone conduction system (Cochlear Osia) provides favorable early clinical and audiometric outcomes in pediatric patients.
• Processor connectivity issues were noted as an area for future device improvement.
• This study represents the largest pediatric case series to date for this technology, supporting its potential in hearing rehabilitation.